EGFR and head and neck squamous cell carcinoma: Several studies have examined the correlation between EGF receptor (EGFR) expression and tumour stage in patients with head and neck squamous cell carcinoma (HNSCC), all concluding that the expression of EGFR is heterogeneous and that the expression of this receptor is independent from tumour stage [29–32].